Menu

Blog

Page 1940

May 15, 2023

Creating the Lab of the Future; What does it entail?

Posted by in categories: biotech/medical, robotics/AI

As part of our SLAS US 2023 coverage, we speak to Luigi Da Via, Team Leader in Analytical Development at GSK, about the lab of the future, and what it may look like.

Please, can you introduce yourself and tell us what inspired your career within the life sciences?

Hello, my name is Luigi Da Via, and I am currently leading the High-Throughput Automation team at GSK. I have been with the company for the past six years, and I’m thrilled to be contributing to the development of life-saving medicines through the application of cutting-edge technology and automation.

May 15, 2023

Dr. Emre Ozcan & Walid Mehanna — Merck KGaA, Darmstadt, Germany — Tech As A Force For Good In Health

Posted by in categories: biotech/medical, business, governance, health, information science

Technology As A Force For Good In People’s Lives — Dr. Emre Ozcan, PhD, VP, Global Head of Digital Health & Walid Mehanna, Group Data Officer And Senior Vice President, Merck KGaA, Darmstadt, Germany.


EPISODE DISCLAIMER — At any time during this episode when anyone says Merck, in any context, it shall always be referring to Merck KGaA, Darmstadt, Germany.

Continue reading “Dr. Emre Ozcan & Walid Mehanna — Merck KGaA, Darmstadt, Germany — Tech As A Force For Good In Health” »

May 15, 2023

Dr. Devi SenGupta, MD, MPhil — Executive Director of Clinical Development, Gilead Sciences

Posted by in category: biotech/medical

EPISODE DISCLAIMER — The views and opinions expressed in this episode are those of the guest and do not necessarily reflect the views or positions of any entities they represent.

Dr. Devi SenGupta, MD, MPhil, is Executive Director of Clinical Development at Gilead Sciences (https://www.gilead.com/), where she leads the company’s HIV cure development program and during her time at the company has led multiple HIV treatment and cure studies. As head of the HIV cure program, she provides strategic direction for cross-functional internal teams and external multi-stakeholder collaborations developing combination approaches aimed at achieving long-term HIV remission.

Continue reading “Dr. Devi SenGupta, MD, MPhil — Executive Director of Clinical Development, Gilead Sciences” »

May 15, 2023

Google Quantum AI Breaks Ground: Unraveling the Mystery of Non-Abelian Anyons

Posted by in categories: particle physics, quantum physics, robotics/AI

Summary: For the first time, Google Quantum AI has observed the peculiar behavior of non-Abelian anyons, particles with the potential to revolutionize quantum computing by making operations more resistant to noise.

Non-Abelian anyons have the unique feature of retaining a sort of memory, allowing us to determine when they have been exchanged, even though they are identical.

The team successfully used these anyons to perform quantum computations, opening a new path towards topological quantum computation. This significant discovery could be instrumental in the future of fault-tolerant topological quantum computing.

May 15, 2023

Stellantis halts battery plant construction over dispute with Canadian govt

Posted by in categories: government, sustainability, transportation

OTTAWA, May 15 (Reuters) — Automaker Stellantis (STLAM.MI) has stopped all construction at a more-than C$5 billion ($3.74 billion) electric vehicle battery manufacturing plant in Windsor, Canada, over a disagreement with the federal government about subsidies, a spokesperson for the company said on Monday.

“Effective immediately, all construction related to the battery module production on the Windsor site has stopped,” the spokesperson said.

Canada’s industry ministry did not immediately respond to a request for comment.

May 15, 2023

SpaceX hires former NASA human spaceflight official Kathy Lueders to help with Starship

Posted by in categories: Elon Musk, space travel

Kathy Lueders, the most recent top human spaceflight official at NASA, has joined Elon Musk’s SpaceX after retiring from the agency a couple of weeks ago, CNBC has learned.

Lueders’ role will be general manager, and she will work out of the company’s “Starbase” facility in Texas, reporting directly to SpaceX president and COO Gwynne Shotwell, people familiar with the matter told CNBC.

It’s a key hire for SpaceX as the company aims to make its massive Starship rocket safe to fly people in the coming years. Lueders, a respected expert in the sector, is already familiar with the company’s human spaceflight work to date.

May 15, 2023

Part 1 on the Race to Create a Permanent Human Presence in Low-Earth-Orbit

Posted by in category: space travel

A commercial space station called Orbital Reef may be deployed this decade, one of many planned for low-Earth orbit.


In Part 1 looking at LEO space station deployment we focus on two front runners: the Axiom Space Station and Blue Origin’s Orbital Reef.

May 15, 2023

The Most Beautiful Strongly Bound Dibaryon

Posted by in categories: cosmology, particle physics

Dibaryons are subatomic particles composed of two baryons. Their formation, which occurs through interactions between baryons, is fundamental in big-bang nucleosynthesis, nuclear reactions including those happening within stars, and bridges the gap between nuclear physics, cosmology, and astrophysics. Fascinatingly, the strong force, responsible for the formation and the majority of the mass of nuclei, facilitates the formation of a plethora of different dibaryons with diverse quark combinations.

Nevertheless, these dibaryons are not commonly observed — the deuteron is currently the only known stable dibaryon.

To resolve this apparent dichotomy, it is essential to investigate dibaryons and baryon-baryon interactions at the fundamental level of strong interactions. In a recent publication in Physical Review Letters.

May 15, 2023

Improving crystal engineering with DNA

Posted by in categories: biotech/medical, engineering, nanotechnology

Northwestern investigators have demonstrated that fine-tuning DNA interaction strength can improve colloidal crystal engineering to enhance their use in creating an array of functional nanomaterials, according to a recent study published in ACS Nano.

Chad Mirkin, Ph.D., professor of Medicine in the Division of Hematology and Oncology, the George B. Rathmann Professor of Chemistry at Northwestern’s Weinberg College of Arts and Sciences, and director of the International Institute for Nanotechnology, was senior author of the study.

Colloidal crystal engineering with DNA involves modifying nanoparticles into programmable atom equivalents, or “PAEs,” which are used to form that can then be used for designing programmable, synthetic DNA sequences.

May 15, 2023

The AI saga continues

Posted by in categories: ethics, Peter Diamandis, robotics/AI

Following up on my last posting on advances — and worries — about Artificial General Intelligence… Peter Diamandis’s latest tech blog is regarding AI and ethics.